Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1744 | 6503 | 37.8 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
1744 | 2 | CATHEPSIN//CATHEPSIN K//CATHEPSIN B | 6503 |
752 | 1 | CATHEPSIN B//CYSTATIN//CATHEPSIN L | 3104 |
7726 | 1 | MANNOSE 6 PHOSPHATE//MANNOSE 6 PHOSPHATE RECEPTOR//I CELL DISEASE | 1335 |
11865 | 1 | CATHEPSIN K//PYCNODYSOSTOSIS//CATHEPSIN K INHIBITOR | 948 |
14530 | 1 | CATHEPSIN D//PROCATHEPSIN D//UNITE HORMONES CANC | 764 |
24803 | 1 | PAPILLON LEFEVRE SYNDROME//CATHEPSIN C//HAIM MUNK SYNDROME | 301 |
37685 | 1 | CELLULAR REPRESSOR OF E1A STIMULATED GENES//CREG//CELLULAR REPRESSOR OF E1A STIMULATED GENES CREG | 51 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CATHEPSIN | authKW | 631974 | 5% | 40% | 340 |
2 | CATHEPSIN K | authKW | 621557 | 3% | 58% | 227 |
3 | CATHEPSIN B | authKW | 601099 | 5% | 37% | 343 |
4 | CATHEPSIN D | authKW | 485723 | 5% | 33% | 315 |
5 | CYSTATIN | authKW | 439477 | 3% | 41% | 227 |
6 | CATHEPSIN L | authKW | 418114 | 3% | 42% | 213 |
7 | PAPILLON LEFEVRE SYNDROME | authKW | 390391 | 1% | 96% | 87 |
8 | CYSTEINE PROTEASE | authKW | 271065 | 4% | 23% | 257 |
9 | CATHEPSIN C | authKW | 212958 | 1% | 74% | 61 |
10 | PYCNODYSOSTOSIS | authKW | 204032 | 1% | 91% | 48 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 15618 | 42% | 0% | 2725 |
2 | Cell Biology | 3659 | 14% | 0% | 900 |
3 | Biophysics | 2789 | 8% | 0% | 552 |
4 | Oncology | 2117 | 11% | 0% | 734 |
5 | Chemistry, Medicinal | 1044 | 5% | 0% | 293 |
6 | Endocrinology & Metabolism | 707 | 5% | 0% | 343 |
7 | Pathology | 426 | 3% | 0% | 195 |
8 | Dentistry, Oral Surgery & Medicine | 372 | 2% | 0% | 160 |
9 | Medicine, Research & Experimental | 362 | 4% | 0% | 260 |
10 | Genetics & Heredity | 280 | 4% | 0% | 275 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM DRUG DESIGN | 103677 | 0% | 82% | 27 |
2 | BIOCHEM MOL STRUCT BIOL | 52679 | 1% | 23% | 48 |
3 | PROT BIOCHEM MOL BIOL | 45054 | 0% | 80% | 12 |
4 | GENET TOXICOL CANC BIOL | 35292 | 0% | 24% | 32 |
5 | DISCOVERY COMPUTAT ANALYT STRUCT SCI | 32856 | 0% | 100% | 7 |
6 | WORLD WIDE PHYS PROPERTIES | 30036 | 0% | 80% | 8 |
7 | GENE EXP S PROT PURIFICAT | 28162 | 0% | 100% | 6 |
8 | UPPSALA BIOMED VET MED CHEM BOX 575 | 23468 | 0% | 100% | 5 |
9 | UNITE HORMONES CANC | 21450 | 0% | 57% | 8 |
10 | MOL MED CELL | 20464 | 1% | 12% | 37 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOLOGICAL CHEMISTRY | 21666 | 2% | 4% | 122 |
2 | BIOLOGICAL CHEMISTRY HOPPE-SEYLER | 21088 | 1% | 5% | 83 |
3 | BIOCHEMICAL JOURNAL | 4544 | 3% | 1% | 173 |
4 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4461 | 6% | 0% | 403 |
5 | FEBS LETTERS | 2003 | 2% | 0% | 139 |
6 | BIOMEDICA BIOCHIMICA ACTA | 1998 | 0% | 1% | 30 |
7 | JOURNAL OF BIOCHEMISTRY | 1846 | 1% | 1% | 67 |
8 | BONE | 1818 | 1% | 1% | 52 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1692 | 2% | 0% | 100 |
10 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 1586 | 1% | 0% | 79 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CATHEPSIN | 631974 | 5% | 40% | 340 | Search CATHEPSIN | Search CATHEPSIN |
2 | CATHEPSIN K | 621557 | 3% | 58% | 227 | Search CATHEPSIN+K | Search CATHEPSIN+K |
3 | CATHEPSIN B | 601099 | 5% | 37% | 343 | Search CATHEPSIN+B | Search CATHEPSIN+B |
4 | CATHEPSIN D | 485723 | 5% | 33% | 315 | Search CATHEPSIN+D | Search CATHEPSIN+D |
5 | CYSTATIN | 439477 | 3% | 41% | 227 | Search CYSTATIN | Search CYSTATIN |
6 | CATHEPSIN L | 418114 | 3% | 42% | 213 | Search CATHEPSIN+L | Search CATHEPSIN+L |
7 | PAPILLON LEFEVRE SYNDROME | 390391 | 1% | 96% | 87 | Search PAPILLON+LEFEVRE+SYNDROME | Search PAPILLON+LEFEVRE+SYNDROME |
8 | CYSTEINE PROTEASE | 271065 | 4% | 23% | 257 | Search CYSTEINE+PROTEASE | Search CYSTEINE+PROTEASE |
9 | CATHEPSIN C | 212958 | 1% | 74% | 61 | Search CATHEPSIN+C | Search CATHEPSIN+C |
10 | PYCNODYSOSTOSIS | 204032 | 1% | 91% | 48 | Search PYCNODYSOSTOSIS | Search PYCNODYSOSTOSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TURK, V , STOKA, V , VASILJEVA, O , RENKO, M , SUN, T , TURK, B , TURK, D , (2012) CYSTEINE CATHEPSINS: FROM STRUCTURE, FUNCTION AND REGULATION TO NEW FRONTIERS.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. VOL. 1824. ISSUE 1. P. 68 -88 | 251 | 75% | 218 |
2 | KIRSCHKE, H , BARRETT, AJ , RAWLINGS, ND , (1995) PROTEINASES .1. LYSOSOMAL CYSTEINE PROTEINASES.PROTEIN PROFILE. VOL. 2. ISSUE 14. P. 1587 -1643 | 593 | 61% | 101 |
3 | FONOVIC, M , TURK, B , (2014) CYSTEINE CATHEPSINS AND EXTRACELLULAR MATRIX DEGRADATION.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1840. ISSUE 8. P. 2560 -2570 | 157 | 74% | 44 |
4 | LECAILLE, F , BROMME, D , LALMANACH, G , (2008) BIOCHEMICAL PROPERTIES AND REGULATION OF CATHEPSIN K ACTIVITY.BIOCHIMIE. VOL. 90. ISSUE 2. P. 208 -226 | 181 | 69% | 68 |
5 | DAHMS, NM , HANCOCK, MK , (2002) P-TYPE LECTINS.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1572. ISSUE 2-3. P. 317-340 | 199 | 67% | 123 |
6 | BERDOWSKA, I , (2004) CYSTEINE PROTEASES AS DISEASE MARKERS.CLINICA CHIMICA ACTA. VOL. 342. ISSUE 1-2. P. 41-69 | 164 | 72% | 109 |
7 | VASILJEVA, O , REINHECKEL, T , PETERS, C , TURK, D , TURK, V , TURK, B , (2007) EMERGING ROLES OF CYSTEINE CATHEPSINS IN DISEASE AND THEIR POTENTIAL AS DRUG TARGETS.CURRENT PHARMACEUTICAL DESIGN. VOL. 13. ISSUE 4. P. 387-403 | 136 | 66% | 196 |
8 | BROMME, D , PANWAR, P , TURAN, S , (2016) CATHEPSIN K OSTEOPOROSIS TRIALS, PYCNODYSOSTOSIS AND MOUSE DEFICIENCY MODELS: COMMONALITIES AND DIFFERENCES.EXPERT OPINION ON DRUG DISCOVERY. VOL. 11. ISSUE 5. P. 457 -472 | 119 | 83% | 0 |
9 | FRIZLER, M , STIRNBERG, M , SISAY, MT , GUTSCHOW, M , (2010) DEVELOPMENT OF NITRILE-BASED PEPTIDIC INHIBITORS OF CYSTEINE CATHEPSINS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 3. P. 294-322 | 128 | 71% | 42 |
10 | NICOTRA, G , CASTINO, R , FOLLO, C , PERACCHIO, C , VALENTE, G , ISIDORO, C , (2010) THE DILEMMA: DOES TISSUE EXPRESSION OF CATHEPSIN D REFLECT TUMOR MALIGNANCY? THE QUESTION: DOES THE ASSAY TRULY MIRROR CATHEPSIN D MIS-FUNCTION IN THE TUMOR?.CANCER BIOMARKERS. VOL. 7. ISSUE 1. P. 47 -64 | 136 | 72% | 13 |
Classes with closest relation at Level 2 |